Esophageal obstruction from a hygroscopic pharmacobezoar containing glucomannan

Clinical Toxicology

Volumn 45, Issue 1, 2007, Pages 80-82

  Vanderbeek, Paul B ^a   Fasano, Charles ^a   O'Malley, Gerald ^a   Hornstein, Jon ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; GELATIN; GLUCAGON; MANNAN; NON PRESCRIPTION DRUG;

ADULT; ARTICLE; BIOPSY; CASE REPORT; DIET THERAPY; DRUG TREATMENT FAILURE; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS OBSTRUCTION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; MEDICAL SPECIALIST; OUTPATIENT CARE; PATIENT ASSESSMENT; UPPER GASTROINTESTINAL TRACT; VOMITING; WETTABILITY;

ADULT; BEZOARS; CATHARTICS; DIETARY FIBER; ESOPHAGEAL STENOSIS; ESOPHAGUS; FEMALE; HUMANS; MANNANS; WETTABILITY;

AMORPHOPHALLUS KONJAC;

EID: 33847048708     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650601006215     Document Type: Article

References (19)

1. Gonzalez Canga A, Fernandez Martinez N, Sahagun AM, Garcia Vieite Diez Liebana MJ, Calle Pardo AP, Castro Robles LJ, Sierra Vega M. Glucomannan: properties and therapeutic applications. Nutr Hosp 2004; 19:45-50.
2. Henry DH, Mitchell AS, Aylward J, Fung MT, Mcewen J, Rohan, A. Glucomannan and the risk of oesophageal obstruction. Br Med Journal 1986; 292:591-592.
3. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes 1984; 8:289-293.
4. Sandeman DR, Clements MR, Perrins EJ. Oesophageal obstruction due to hygroscopic gum laxative. Lancet 1980 Feb 16; (8164):364-365.
5. Jones KR, Pillsbury HC. Cellulose fiber diet pills. Arch Otolaryngol Head Neck Surg 1990; 116:1091.
6. Morse JM, Malloy WX. Esophageal obstruction caused by Cal-Ban. Gastroenterology 1990; 98:805-807.
7. Taylor JR, Streetman DS, Castle SS. Medication bezoars: A literature review and report of a case. Ann Pharmacother 1998; 32:940-946.
8. Stack PE, Thomas E. Pharmacobezoar: An evolving new entity. Dig Dis 1995; 13:356-364.
9. Elgood C. A treatise on the bezoar stone: By the late Mahamud bin Masud the Imad-ul-din the physician of Ispahan. Ann Med Hist 1935; 7:73-80.
10. Schneider RP. Perdiem causes esophageal impaction and bezoars. Southern Medical Journal 1989; 82:1449-1450.
11. Ku MT. Bezoars. Clinical Toxicology Review 1996; 18:1-4.
12. Seidner DL, Roberts IM, Smith MS. Esophageal obstruction after ingestion of a fiber-containing diet pill. Gastroenterology 1990; 99:1820-1822.
13. Pfau PR, Ginsberg GG. Foreign bodies and bezoars. In Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: Elsevier 2002.
14. Lewis JH. Esophageal and small bowel obstruction from guar gum containing "diet pills": analysis of 26 cases reported in the Food and Drug Administration. Am J Gastroenterology 1992; 87:1424-1428.
15. Willis J. About body wraps, pills and other magic wands for losing weight. U.S. FDA: FDA Consumer, November 1982.
16. U.S. FDA-CFSAN/Office of Nutritional Products, labelling and dietary supplements. Claims that can be made for conventional foods and dietary supplements. CFSAN September 2003.
17. Shaffer M. Incorrect labelling of non-prescription drugs. U.S. FDA News Release August 26, 2003.
18. U.S. FDA. Dietary Supplement Health and Education Act of 1994: Public law 103-417, 103rd Congress. October 25, 1994.
19. U.S. FDA. Konjac candy recalls. US FDA News Release, January 2002.